This independent, strategic agency describes itself as “Beyond the Science Quo,” with a fearlessly scientific spirit. Revenue at the agency grew to $32.9 million in 2020, with significant wins from Regeneron global development, Takeda rare immunology and GlaxoSmithKline global vaccines. The firm also launched a medical communications offering, and its Let Me Be Clear program for AbbVie set a new standard for meaningful communication with psoriasis patients.
Thank you for accessing MM+M.
Create your free account or log in to continue reading this premium content.